Background: Right ventricular (RV) adaptation to acute and chronic pulmonary hypertensive
syndromes is a significant determinant of short-and long-term outcomes. Although …

Patients with pulmonary hypertension associated with congenital heart disease make up an
increasing proportion of the total pulmonary hypertension population who bring with them …

The diagnosis and management of pulmonary arterial hypertension (PAH) includes several
advances, such as a broader recognition of extrapulmonary vascular organ system …

Rationale: There is a noticeable underrepresentation of minorities in clinical trials and
registries in pulmonary arterial hypertension (PAH). Prior studies evaluating the association …

Pulmonary hypertension (PH) is a clinical condition characterised by elevation of pulmonary
arterial pressure (PAP) above normal range due to various aetiologies. While cardiac right …

BACKGROUND Prior research has suggested that the prevalence and outcomes of
pulmonary arterial hypertension (PAH) may vary by race or ethnicity. However, these studies …

There is expansive literature documenting the presence of health disparities, but there are
disproportionately few studies describing interventions to reduce disparity. In this narrative …

Social determinants of health (SDoH) can impact the vulnerable pulmonary arterial
hypertension (PAH) population, especially during the COVID‐19 pandemic. Providers' …

Conflict of interest statements: Dr RJ Bernardo serves on the medical advisory board for
Janssen Pharmaceuticals. Dr VA de Jesus Perez has no conflict of interest to declare …

Compared to idiopathic pulmonary arterial hypertension (IPAH), patients with
portopulmonary hypertension (POPH) have worse survival. Health disparities may contribute …